{"organizations": [], "uuid": "b6d6a419e8c6a99fadf00e90313404ec3fc173ed", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180125.html", "section_title": "Archive News &amp; Video for Thursday, 25 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-yantai-dongcheng-biochemicals-says/brief-yantai-dongcheng-biochemicals-says-merger-between-two-subsidiaries-idUSL4N1PK3DQ", "country": "US", "domain_rank": 408, "title": "BRIEF-Yantai Dongcheng Biochemicals says merger between two subsidiaries", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.976, "site_type": "news", "published": "2018-01-25T17:05:00.000+02:00", "replies_count": 0, "uuid": "b6d6a419e8c6a99fadf00e90313404ec3fc173ed"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-yantai-dongcheng-biochemicals-says/brief-yantai-dongcheng-biochemicals-says-merger-between-two-subsidiaries-idUSL4N1PK3DQ", "ord_in_thread": 0, "title": "BRIEF-Yantai Dongcheng Biochemicals says merger between two subsidiaries", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "yantai dongcheng beifang p", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-yantai dongcheng biochemicals", "sentiment": "negative"}, {"name": "yantai dongcheng biochemicals co ltd", "sentiment": "negative"}, {"name": "harmaceutical co.,ltd", "sentiment": "none"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "yantai dongcheng dayang pharmaceutical co.", "sentiment": "none"}, {"name": "yantai dongcheng beifang pharmaceutical co.", "sentiment": "none"}, {"name": "ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 25 (Reuters) - Yantai Dongcheng Biochemicals Co Ltd :\n* Says its unit Yantai Dongcheng Beifang Pharmaceutical Co.,Ltd plans to merge with unit Yantai Dongcheng Dayang Pharmaceutical Co.,Ltd\n* Yantai Dongcheng Beifang Pharmaceutical Co.,Ltd will survive and Yantai Dongcheng Dayang Pharmaceutical Co.,Ltd will be dissolved after merger\nSource text in Chinese: goo.gl/G5i5Ef\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/G5i5Ef", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-25T17:05:00.000+02:00", "crawled": "2018-01-26T21:28:19.050+02:00", "highlightTitle": ""}